SBN 0.00% 0.0¢ sun biomedical limited

The exclusivity period concludes on 15th jan so hopefully some...

  1. 3,657 Posts.
    lightbulb Created with Sketch. 533
    The exclusivity period concludes on 15th jan so hopefully some news on this acquisition/arrangement soon. I'm also expecting an update re Oraline.

    They are in the right space in 2014, and with new management, a low market cap, and a bit of cash, SBN has a good shot at creating some serious value from these levels IMO. I reckon howard digby (also director of CYP) could be they key driver now he is executive chairman.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.